Unknown PHASE4 INTERVENTIONAL 2-arm NCT01313247

Paracetamol for Cancer Pain

Optimizing Medication for Cancer Pain. The Effect of Paracetamol. A Clinical and Pharmacological Trial to Research Whether Paracetamol Gives an Additional Effect on Pain Relief When the Patient is Treated With High Doses of Opioids

Sponsor: Haraldsplass Deaconess Hospital

Conditions Advanced Cancer Opioid Use, Unspecified

Interventions paracetamol placebo tablets

Updated 4 times since 2017 Last updated: Mar 10, 2011 Started: Apr 30, 2011 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Advanced Cancer and Opioid Use, Unspecified and is currently ongoing. Haraldsplass Deaconess Hospital leads this study, which shows 4 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Haraldsplass Deaconess Hospital

Data source: Haraldsplass Deaconess Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bergen, Norway